Alexza Pharmaceuticals
IPO
- Headquarters
- Mountain View, California
- Employees
- 51–200
- Founded
- 2002
- Business Model
- B2B
- Website
- alexza.com
- Total Funding
- $124.5M
- Last Round
- $20.0M Series DJul 2012
About
Founded in 2000 and headquartered in Mountain View, California, Alexza Pharmaceuticals developed and commercialized products based on its proprietary Staccato system — a hand-held single-use inhaler delivering pure drug aerosols to the deep lung for rapid systemic delivery. Its lead commercial product was Adasuve (loxapine), an inhaled antipsychotic for acute agitation associated with schizophrenia or bipolar disorder. Alexza was acquired by Grupo Ferrer Internacional in June 2016 and now operates as part of the Ferrer group.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account